Entera Bio (ENTX) Operating Margin Growth (5y) (2024)

Entera Bio (ENTX) Operating Margin Growth (5y) (2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.60 Bn	130.75 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.93 Bn	77.93 Bn	3.93 Bn
3	Argenx Se	65.06 Bn	59.88 Bn	1.37 Bn
4	Moderna	56.22 Bn	51.08 Bn	52.00 Mn
5	BeOne Medicines	42.03 Bn	36.93 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.65 Bn	28.34 Bn	992.69 Mn
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.48 Bn	-
10	Entera Bio	164.47 Mn	153.16 Mn	-

Download Data

Date	Value
Jun 30, 2024	-111,776.00